USE OF 6-PHOSPHOGLUCONATE DEHYDROGENASE AS A SCREEN TEST FOR CERVICAL CARCINOMA IN NORMAL WOMEN

G G MUIR, MUIR GG, CANTI G, G CANTI, D. Williams, Williams D
British medical journal · 1964 · vol. 2(5424) , pp. 1563–5 · doi:10.1136/bmj.2.5424.1563 · PMID:14211756 · PMC1817581
Other OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-25 ⓘ

The study evaluated the utility of 6-phosphogluconate dehydrogenase as a screening test for cervical carcinoma in normal women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Carcinoma Carcinoma, Squamous Cell Cervix Mucus Cytodiagnosis Histocytochemistry Mass Screening Neoplasms Neoplasms Phosphogluconate Dehydrogenase Uterine Cervical Neoplasms Female Humans Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:01:56.755204+00:00